Study Summary
This trial is testing a new way to give radiation and chemotherapy to patients with stage II-III NSCLC that can't be removed by surgery. The new way may kill more tumor cells and spare more healthy tissue.
- Non-Small Cell Lung Cancer
- Squamous Cell Carcinoma of the Lung
- Stage IIIA Non-small Cell Lung Cancer
- Stage IIB Non-small Cell Lung Cancer
- Lung Adenocarcinoma
- Stage IIA Non-small Cell Lung Cancer
- Non-small Cell Lung Cancer (NSCLC), Recurrent
- Adenosquamous Cell Lung Cancer
- Non-small Cell Lung Cancer Stage IIIB
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 3 Secondary · Reporting Duration: participants will be followed for 2 years
Trial Safety
Safety Progress
Side Effects for
Trial Design
1 Treatment Group
Treatment (dose-escalation of RT)
1 of 1
Experimental Treatment
29 Total Participants · 1 Treatment Group
Primary Treatment: carboplatin · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 5 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
To what extent is the study participant pool expanding?
"This clinical trial has ceased recruitment, with the posting dated March 23rd 2011 and its last update on December 2nd 2021. For those still looking for medical studies, 1949 trials involving lung cancer are currently open to applicants as well as 1177 trails offering carboplatin treatment." - Anonymous Online Contributor
What conditions does carboplatin typically address?
"Physcians can utilise carboplatin to aid in the management of melanoma, neoplasm metastasis, and non-hodgkin lymphoma." - Anonymous Online Contributor
Is enrollment for this trial still open to the public?
"This clinical trial is not actively recruiting participants. The initial post date was March 23, 2011 and the last update occurred on December 2nd of 2021. However there are 1949 studies related to lung cancer and 1177 trials involving carboplatin that are currently searching for eligible candidates." - Anonymous Online Contributor
What additional experiments have occurred involving carboplatin?
"Presently, 1177 clinical trials are in progress studying the effects of carboplatin with 333 of them being Phase 3. Concentrated mainly around Shanghai, there are 66707 medical centres examining this medication." - Anonymous Online Contributor